These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35080423)

  • 1. Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice.
    Wong TY; Horspool AM; Russ BP; Ye C; Lee KS; Winters MT; Bevere JR; Miller OA; Rader NA; Cooper M; Kieffer T; Sourimant J; Greninger AL; Plemper RK; Denvir J; Cyphert HA; Barbier M; Torrelles JB; Martinez I; Martinez-Sobrido L; Damron FH
    J Virol; 2022 Mar; 96(6):e0218421. PubMed ID: 35080423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
    Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
    mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.
    Barbier M; Lee KS; Vikharankar MS; Rajpathak SN; Kadam N; Wong TY; Russ BP; Cyphert HA; Miller OA; Rader NA; Cooper M; Kang J; Sen-Kilic E; Wong ZY; Winters MT; Bevere JR; Martinez I; Devarumath R; Shaligram US; Damron FH
    Front Immunol; 2022; 13():948431. PubMed ID: 36091051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
    Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
    mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Corzo C; Noriega MA; Sánchez-Cordón PJ; Labiod N; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2024; 15():1420304. PubMed ID: 39267752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern
    Chiem K; Morales Vasquez D; Silvas JA; Park JG; Piepenbrink MS; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Walter MR; de la Torre JC; Kobie JK; Ye C; Martinez-Sobrido L
    J Virol; 2021 Oct; 95(22):e0112621. PubMed ID: 34495697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains.
    Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H
    Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice.
    Lee KS; Wong TY; Russ BP; Horspool AM; Miller OA; Rader NA; Givi JP; Winters MT; Wong ZYA; Cyphert HA; Denvir J; Stoilov P; Barbier M; Roan NR; Amin MS; Martinez I; Bevere JR; Damron FH
    PLoS One; 2022; 17(8):e0273430. PubMed ID: 36037222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
    Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
    mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.
    Hoffmann D; Corleis B; Rauch S; Roth N; Mühe J; Halwe NJ; Ulrich L; Fricke C; Schön J; Kraft A; Breithaupt A; Wernike K; Michelitsch A; Sick F; Wylezich C; Hoffmann B; Thran M; Thess A; Mueller SO; Mettenleiter TC; Petsch B; Dorhoi A; Beer M
    Nat Commun; 2021 Jun; 12(1):4048. PubMed ID: 34193869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
    Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
    Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice.
    Natekar JP; Pathak H; Stone S; Kumari P; Sharma S; Auroni TT; Arora K; Rothan HA; Kumar M
    Viruses; 2022 May; 14(6):. PubMed ID: 35746611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case.
    Tatham L; Kipar A; Sharp J; Kijak E; Herriott J; Neary M; Box H; Gallardo Toledo E; Valentijn A; Cox H; Pertinez H; Curley P; Arshad U; Rajoli RKR; Rannard S; Stewart JP; Owen A
    Microbiol Spectr; 2024 Aug; 12(8):e0391623. PubMed ID: 39012120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy.
    Horspool AM; Ye C; Wong TY; Russ BP; Lee KS; Winters MT; Bevere JR; Kieffer T; Martinez I; Sourimant J; Greninger A; Plemper RK; Denvir J; Cyphert HA; Torrelles J; Martinez-Sobrido L; Damron FH
    bioRxiv; 2021 May; ():. PubMed ID: 33972945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.